# Clinical trials recruiting in North Dakota: 225 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 225 trials recruiting or not yet recruiting with a site in North Dakota, as read on November 19, 2026.

## The full list

Clinical trials recruiting in North Dakota: 225 rows for $11.25, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/north-dakota

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 225
- Recruiting or not yet: 225
- Read on: November 19, 2026

## Trials

The 25 newest of 225, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07930494 | Feasibility of Remote Blood Pressure Monitoring to Improve Management of Hypertensive Disorders of Pregnancy | Sanford Health | Not applicable | Not yet recruiting | Hypertensive Disorders of Pregnancy (HDP) | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930494) |
| November 6, 2026 | NCT07923045 | A Phase 1/2 Clinical Trial to Evaluate the Safety and Efficacy of MR-146 in Subjects With Stage I and Stage II Neurotrophic Keratopathy | Viatris Inc. | Phase 1/2 | Recruiting | Neurotrophic Keratopathy | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923045) |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861100) |
| September 18, 2026 | NCT07828860 | Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa | Corvus Pharmaceuticals, Inc. | Phase 1 | Recruiting | Hidradenitis Suppurativa (HS) | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828860) |
| September 11, 2026 | NCT07816367 | A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | TriGemX Bio, Inc. | Phase 3 | Recruiting | Migraine | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816367) |
| August 31, 2026 | NCT07794579 | A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1... | Eli Lilly and Company | Phase 3 | Recruiting | Overweight, Prediabetic State, Prehypertension, Obesity, Abdominal | 2,001 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07794579) |
| August 25, 2026 | NCT07784725 | A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2... | AstraZeneca | Phase 3 | Recruiting | Obesity or Overweight | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784725) |
| August 20, 2026 | NCT07776509 | A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With... | AstraZeneca | Phase 3 | Recruiting | Obesity or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2 | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07776509) |
| August 20, 2026 | NCT07775495 | Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure | Ecotera Health LLC | Observational | Recruiting | Healthy Adult Participants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775495) |
| August 14, 2026 | NCT07765888 | A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema | Pfizer | Phase 3 | Recruiting | Atopic Dermatitis | 375 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07765888) |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761117) |
| August 7, 2026 | NCT07752979 | Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities | AbbVie | Phase 2 | Recruiting | Obesity, Overweight | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07752979) |
| June 25, 2026 | NCT07668414 | A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide | Novo Nordisk A/S | Phase 3 | Recruiting | Overweight, Obesity | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07668414) |
| June 25, 2026 | NCT07668388 | A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes | Novo Nordisk A/S | Phase 2 | Recruiting | Diabetes Mellitus, Type 2 | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07668388) |
| June 16, 2026 | NCT07650708 | A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK | Vance Thompson Vision | Phase 4 | Recruiting | Dry Eye Syndrome (DES), Dry Eye Disease (DED) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07650708) |
| June 11, 2026 | NCT07641517 | A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain | Eli Lilly and Company | Phase 2 | Recruiting | Osteoarthritis, Knee, Chronic Pain | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641517) |
| June 11, 2026 | NCT07641504 | A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain | Eli Lilly and Company | Phase 2 | Recruiting | Chronic Pain, Low Back Pain | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641504) |
| June 5, 2026 | NCT07630974 | A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) | Merck Sharp & Dohme LLC | Phase 1/2 | Recruiting | Malignant Neoplasm | 134 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630974) |
| June 4, 2026 | NCT07626411 | Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation | Regeneron Pharmaceuticals | Phase 3 | Recruiting | Atrial Fibrillation (AF) | 15,364 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07626411) |
| June 1, 2026 | NCT07619118 | A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With... | AstraZeneca | Phase 3 | Recruiting | Hypercholesterolaemia | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07619118) |
| May 20, 2026 | NCT07599813 | A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis | Apollo Therapeutics Ltd | Phase 2 | Recruiting | Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic, Dermatologic Disease, Eczema, Eczema Atopic Dermatitis... | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07599813) |
| May 20, 2026 | NCT07598149 | Glucose Levels and Outcomes in Women - Mid Pregnancy | Sanford Health | Observational | Recruiting | Pregnancy | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07598149) |
| May 15, 2026 | NCT07591389 | Promoting Radon Testing Among Mothers of Young Children | University of North Dakota | Not applicable | Recruiting | Lung Cancer (Diagnosis) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07591389) |
| May 6, 2026 | NCT07571109 | AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep... | Novo Nordisk A/S | Phase 3 | Recruiting | Obesity, Overweight, Obstructive Sleep Apnoea | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07571109) |
| May 4, 2026 | NCT07564414 | A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or... | Novo Nordisk A/S | Phase 3 | Recruiting | Obesity, Type 2 Diabetes | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07564414) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Sanford Broadway Medical Center | Fargo | 88 |
| Sanford Roger Maris Cancer Center | Fargo | 71 |
| Sanford Bismarck Medical Center | Bismarck | 61 |
| Essentia Health Cancer Center-South University Clinic | Fargo | 49 |
| Essentia Health - Jamestown Clinic | Jamestown | 23 |
| Sanford South University Medical Center | Fargo | 19 |
| Sanford Medical Center Fargo | Fargo | 18 |
| Southpointe-Sanford Medical Center Fargo | Fargo | 17 |
| Sanford Health | Fargo | 10 |
| Altru Cancer Center | Grand Forks | 9 |
| Sanford Fargo Medical Center | Fargo | 8 |
| Sanford Fargo Medical Center-Roger Maris Cancer Center | Fargo | 7 |
| Lillestol Research | Fargo | 7 |
| Lillestol Research LLC | Fargo | 6 |
| Altru Health System | Grand Forks | 5 |
| Trinity Cancer Care Center | Minot | 4 |
| Red River Research Partners, LLC | Fargo | 3 |
| Sanford Medical Center | Fargo | 3 |
| Lillestol Research, LLC | Fargo | 2 |
| Plains Clinical Research Center | Fargo | 2 |
| Sanford Health Roger Maris Cancer Center | Fargo | 2 |
| University of North Dakota | Grand Forks | 2 |
| USDA Grand Forks Human Nutrition Research Center | Grand Forks | 2 |
| Red River Research Partners | Fargo | 2 |
| AXIS Clinicals - Fargo | Fargo | 2 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Phase 1/2 | 9 |
| Phase 2 | 52 |
| Phase 2/3 | 10 |
| Phase 3 | 102 |
| Phase 4 | 2 |
| Not applicable | 15 |
| Observational | 30 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Lung Neoplasms | 16 |
| Carcinoma, Non-Small-Cell Lung | 16 |
| Breast Neoplasms | 11 |
| Neoplasms | 11 |
| Obesity | 9 |
| Melanoma | 9 |
| Prostatic Neoplasms | 9 |
| Overweight | 8 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
| Colorectal Neoplasms | 7 |
| Leukemia, Myeloid, Acute | 7 |
| Pancreatic Neoplasms | 7 |
| Diabetes Mellitus, Type 2 | 6 |
| Burkitt Lymphoma | 6 |
| Colonic Neoplasms | 6 |
| Rectal Neoplasms | 6 |
| Multiple Myeloma | 6 |
| Carcinoma | 6 |
| Endometrial Neoplasms | 6 |
| Urinary Bladder Neoplasms | 6 |
| Dermatitis, Atopic | 5 |
| Mouth Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
| Myelodysplastic Syndromes | 5 |
| Laryngeal Neoplasms | 5 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 35 |
| Alliance for Clinical Trials in Oncology | 19 |
| SWOG Cancer Research Network | 16 |
| Children's Oncology Group | 16 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 15 |
| NRG Oncology | 13 |
| Sanford Health | 7 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 7 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 7 |
| ECOG-ACRIN Cancer Research Group | 7 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 6 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 6 |
| Tempus AI | 3 |
| Canadian Cancer Trials Group | 3 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 2 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 2 |
| Vance Thompson Vision | 2 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 2 |
| Mayo Clinic | 2 |
| Jaeb Center for Health Research | 2 |
| USDA Grand Forks Human Nutrition Research Center | 2 |
| Wake Forest University Health Sciences | 2 |
| Washington University School of Medicine | 2 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in North Dakota

- [Buffet restaurants in North Dakota, United States](https://specstream.ai/data/businesses/buffet-restaurants/north-dakota-united-states)
- [Restaurants in North Dakota, United States](https://specstream.ai/data/businesses/restaurants/north-dakota-united-states)
- [Marketing agencies in North Dakota, United States](https://specstream.ai/data/businesses/marketing-agencies/north-dakota-united-states)
- [Energy companies in North Dakota, United States](https://specstream.ai/data/businesses/energy-companies/north-dakota-united-states)
- [Bar and grill restaurants in North Dakota, United States](https://specstream.ai/data/businesses/bar-and-grill-restaurants/north-dakota-united-states)
- [Pubs in North Dakota, United States](https://specstream.ai/data/businesses/pubs/north-dakota-united-states)
